|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-5-28
|
|
pubmed:abstractText |
Urinary liver-type fatty acid-binding protein (u-LFABP) is a marker of tubulointerstitial inflammation and has been shown to be increased in patients with type 1 diabetes and is further increased in patients who progress to micro- and macroalbuminuria. Our aim was to evaluate u-LFABP as a predictor of progression to micro- and macroalbuminuria in type 1 diabetes.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-11696003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-12663607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-1280113,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-15096438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-15466390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-15871303,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-16249547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-17907053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-18375412,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-19435794,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-19502542,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-20690201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20185732-9082452
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1935-5548
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1320-4
|
|
pubmed:dateRevised |
2011-7-28
|
|
pubmed:meshHeading |
pubmed-meshheading:20185732-Adult,
pubmed-meshheading:20185732-Albuminuria,
pubmed-meshheading:20185732-Creatinine,
pubmed-meshheading:20185732-Diabetes Mellitus, Type 1,
pubmed-meshheading:20185732-Diabetic Nephropathies,
pubmed-meshheading:20185732-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20185732-Fatty Acid-Binding Proteins,
pubmed-meshheading:20185732-Female,
pubmed-meshheading:20185732-Humans,
pubmed-meshheading:20185732-Male,
pubmed-meshheading:20185732-Middle Aged,
pubmed-meshheading:20185732-Proportional Hazards Models,
pubmed-meshheading:20185732-Risk Factors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients.
|
|
pubmed:affiliation |
Steno Diabetes Center, Gentofte, Denmark. sene@steno.dk
|
|
pubmed:publicationType |
Journal Article
|
